|
|||||
|
|
Conceptual Changes in Cancer Chemotherapy: From an Oral Fluoropyrimidine Prodrug, UFT, to a Novel Oral Fluoropyrimidine Prodrug, S-1, and Low-Dose FP Therapy in Japan |
|
| Authors: | Tetsuhiko Shirasaka Susumu Yamamitsu Akihito Tsuji Tetsuo Taguchi |
| Affiliation: | (1) Lab. Pathogenic Biochemistry in Medicine, Taiho Pharmaceutical Co., Ltd., Tokyo, Japan;(2) Sapporo Tsukisamu Hospital, Sapporo, Japan;(3) Kochi Municipal Center Hospital, Kochi, Japan;(4) Japanese Society for Cancer Chemotherapy, Osaka, Japan |
| Abstract: | |
| Keywords: | biochemical modulation of 5-FU CDHP (DPD) inhibitor low-dose FP therapy oxo (potassium oxonate) S-1 UFT |
| 本文献已被 PubMed SpringerLink 等数据库收录！ | |